skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 7,253  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Therapeutic Targeting of the Tumor Microenvironment
Material Type:
Article
Add to My Research

Therapeutic Targeting of the Tumor Microenvironment

Cancer discovery, 2021-04, Vol.11 (4), p.933-959

2021 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-20-1808 ;PMID: 33811125

Full text available

2
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Material Type:
Article
Add to My Research

Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

Cancer cell, 2014-11, Vol.26 (5), p.605-622 [Peer Reviewed Journal]

2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;2014 Elsevier Inc. All rights reserved. 2014 ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2014.10.006 ;PMID: 25517747

Full text available

3
Current treatment and recent progress in gastric cancer
Material Type:
Article
Add to My Research

Current treatment and recent progress in gastric cancer

CA: a cancer journal for clinicians, 2021-05, Vol.71 (3), p.264-279 [Peer Reviewed Journal]

2021 American Cancer Society ;2021 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. May/Jun 2021 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21657 ;PMID: 33592120

Full text available

4
Tumor angiogenesis: causes, consequences, challenges and opportunities
Material Type:
Article
Add to My Research

Tumor angiogenesis: causes, consequences, challenges and opportunities

Cellular and molecular life sciences : CMLS, 2020-05, Vol.77 (9), p.1745-1770 [Peer Reviewed Journal]

The Author(s) 2019 ;The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1420-682X ;ISSN: 1420-9071 ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-019-03351-7 ;PMID: 31690961

Full text available

5
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy
Material Type:
Article
Add to My Research

Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy

Clinical cancer research, 2023-01, Vol.29 (1), p.30-39 [Peer Reviewed Journal]

2022 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-22-1366 ;PMID: 35969170

Full text available

6
The impact of VEGF on cancer metastasis and systemic disease
Material Type:
Article
Add to My Research

The impact of VEGF on cancer metastasis and systemic disease

Seminars in cancer biology, 2022-11, Vol.86 (Pt 3), p.251 [Peer Reviewed Journal]

ISSN: 1096-3650 ;EISSN: 1096-3650 ;DOI: 10.1016/j.semcancer.2022.03.011

Digital Resources/Online E-Resources

7
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Material Type:
Article
Add to My Research

Treatment of muscle‐invasive and advanced bladder cancer in 2020

CA: a cancer journal for clinicians, 2020-09, Vol.70 (5), p.404-423 [Peer Reviewed Journal]

2020 American Cancer Society ;2020 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Sep/Oct 2020 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21631 ;PMID: 32767764

Full text available

8
The Role of Angiogenesis in Hepatocellular Carcinoma
Material Type:
Article
Add to My Research

The Role of Angiogenesis in Hepatocellular Carcinoma

Clinical cancer research, 2019-02, Vol.25 (3), p.912-920 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1254 ;PMID: 30274981

Full text available

9
Ten years of anti-vascular endothelial growth factor therapy
Material Type:
Article
Add to My Research

Ten years of anti-vascular endothelial growth factor therapy

Nature reviews. Drug discovery, 2016-06, Vol.15 (6), p.385-403 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2015.17 ;PMID: 26775688

Full text available

10
Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both?
Material Type:
Article
Add to My Research

Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both?

Cancer research (Chicago, Ill.), 2022-01, Vol.82 (1), p.15-17 [Peer Reviewed Journal]

2022 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-21-3515 ;PMID: 34983784

Full text available

11
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Material Type:
Article
Add to My Research

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Nature reviews. Clinical oncology, 2018-05, Vol.15 (5), p.325-340 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group May 2018 ;Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2018. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2018.29 ;PMID: 29508855

Full text available

12
Therapeutic targeting of the angiopoietin-TIE pathway
Material Type:
Article
Add to My Research

Therapeutic targeting of the angiopoietin-TIE pathway

Nature reviews. Drug discovery, 2017-09, Vol.16 (9), p.635-661 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2017 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.278 ;PMID: 28529319

Full text available

13
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

The Lancet (British edition), 2017-02, Vol.389 (10068), p.519-527 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 4, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31594-X ;PMID: 28017406 ;CODEN: LANCAO

Full text available

14
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Material Type:
Article
Add to My Research

Macrophage Regulation of Tumor Responses to Anticancer Therapies

Cancer cell, 2013-03, Vol.23 (3), p.277-286 [Peer Reviewed Journal]

2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccr.2013.02.013 ;PMID: 23518347

Full text available

15
Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
Material Type:
Article
Add to My Research

Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

Nature reviews. Clinical oncology, 2021-08, Vol.18 (8), p.527-540 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-021-00496-y ;PMID: 33833434

Full text available

16
Basic and Therapeutic Aspects of Angiogenesis
Material Type:
Article
Add to My Research

Basic and Therapeutic Aspects of Angiogenesis

Cell, 2011-09, Vol.146 (6), p.873-887 [Peer Reviewed Journal]

2011 Elsevier Inc. ;Copyright © 2011 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2011.08.039 ;PMID: 21925313

Full text available

17
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Material Type:
Article
Add to My Research

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

Angiogenesis (London), 2017-11, Vol.20 (4), p.409-426 [Peer Reviewed Journal]

Springer Science+Business Media B.V. 2017 ;Angiogenesis is a copyright of Springer, 2017. ;ISSN: 0969-6970 ;EISSN: 1573-7209 ;DOI: 10.1007/s10456-017-9562-9 ;PMID: 28660302

Full text available

18
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
Material Type:
Article
Add to My Research

Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches

International journal of molecular sciences, 2016-09, Vol.17 (9), p.1534-1534 [Peer Reviewed Journal]

2016 by the authors; licensee MDPI, Basel, Switzerland. 2016 ;ISSN: 1422-0067 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms17091534 ;PMID: 27649147

Full text available

19
Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions
Material Type:
Article
Add to My Research

Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions

British journal of ophthalmology, 2022-03, Vol.106 (3), p.297-304 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-318452 ;PMID: 33741584

Full text available

20
Vascular normalisation as the stepping stone into tumour microenvironment transformation
Material Type:
Article
Add to My Research

Vascular normalisation as the stepping stone into tumour microenvironment transformation

British journal of cancer, 2021-08, Vol.125 (3), p.324-336 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01330-z ;PMID: 33828258

Full text available

Results 1 - 20 of 7,253  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (6,797)

Refine My Results

Creation Date 

From To
  1. Before 2001  (118)
  2. 2001 To 2005  (701)
  3. 2006 To 2010  (1,705)
  4. 2011 To 2016  (3,094)
  5. After 2016  (1,636)
  6. More options open sub menu

Language 

  1. English  (7,013)
  2. Japanese  (1,274)
  3. Spanish  (89)
  4. German  (65)
  5. French  (64)
  6. Portuguese  (56)
  7. Chinese  (12)
  8. Polish  (10)
  9. Czech  (9)
  10. Norwegian  (7)
  11. Italian  (6)
  12. Swedish  (6)
  13. Hungarian  (5)
  14. Russian  (3)
  15. Korean  (2)
  16. Icelandic  (2)
  17. Slovak  (1)
  18. Turkish  (1)
  19. Dutch  (1)
  20. More options open sub menu

Searching Remote Databases, Please Wait